Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells-Reference-Cited by-同舟云学术

Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells

Published:2014-02-25 Issue:5 Volume:137 Page:1481-1495
ISSN:1460-2156
Container-title:Brain
language:en
Short-container-title:

Author:

McNeill Alisdair,Magalhaes Joana,Shen Chengguo,Chau Kai-Yin,Hughes Derralyn,Mehta Atul,Foltynie Tom,Cooper J. Mark,Abramov Andrey Y.,Gegg Matthew,Schapira Anthony H.V.

Publisher

Oxford University Press (OUP)

Subject

Clinical Neurology

Link

http://academic.oup.com/brain/article-pdf/137/5/1481/13797138/awu020.pdf

Reference47 articles.

1. Chaperone-mediated autophagy markers in Parkinson disease brains;Alvarez-Erviti;Arch Neurol,2010

2. Cell surface associated glycohydrolases in normal and Gaucher disease fibroblasts;Aureli;J Inherit Metab Dis,2012

3. Type I Gaucher disease;Balwani;Arch Intern Med,2010

4. Ambroxol acts as a pharmacological chaperone for mutant glucocerebrosidase;Bendikov-Bar;Blood Cells Mol Dis,2013

5. Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome;Campeau;Blood,2009

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease;Translational Neurodegeneration;2024-09-12

2. Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies;Cellular and Molecular Life Sciences;2024-09-03

3. Molecular mechanisms of the ambroxol action in Gaucher disease and GBA1 mutation-associated Parkinson disease;Neurochemistry International;2024-09

4. A PIKfyve modulator combined with an integrated stress response inhibitor to treat lysosomal storage diseases;Proceedings of the National Academy of Sciences;2024-08-16

5. Pharmacological GCase Activity Enhancement Inhibits Tau Accumulation;2024-08-13